What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020).

In this cross-sectional study, line of therapy, study phase and manufacturer were the only factors associated with accrual rate. These findings suggest many proffered factors for speedy trial accrual are not associated with greater enrolment rates.